Wednesday, March 06, 2013 (7:30 AM - 12:00 PM)
Topic Description: It’s no secret that funding a life science business is harder than ever. The contraction of venture capital and cuts to federal grant budgets have made securing non-dilutive funding more difficult, yet ever more crucial to validating technology and reducing risk early on. Don’t miss this event if you want learn more about the varied sources of non-dilute capital available to life science companies in Washington and how best to go about finding it, getting it, and using it smartly.
This is Part I of a 2-part series. Part II, focused on venture capital, will be held at LSINW July 10-11, 2013.
Who Should Attend:
Our Expert Panelists:
Registration Fees:WBBA Member- $40.00 Future Member- $80.00 Academia, Nonprofit, Student- $35.00 Thank you to our sponsors:
1551 Eastlake Avenue East
Seattle, WA 98102 United States
© 2012 Washington Biotechnology & Biomedical Association